CAL 101,
CAL-101,
CAL101,
GS-1101,
idelalisib,
Zydelig,
Idelalisib,
870281-82-6,
CAL-101,
Zydelig,
GS-1101,
CAL 101,
CAL101,
(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one,
UNII-YG57I8T5M0,
CAL-101 (Idelalisib, GS-1101),
YG57I8T5M0,
CHEMBL2216870,
CHEBI:82701,
(S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one,
5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one,
Idelalisib; CAL-101,
1146702-54-6,
5-fluoro-3-phenyl-2-((1s)-1-(9h-purin-6-ylamino)propyl)-4(3h)-quinazolinone,
5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one,
5-Fluoro-3-Phenyl-2-[(1s)-1-(7h-Purin-6-Ylamino)propyl]quinazolin-4(3h)-One,
5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE,
Idelalisib [USAN:INN],
AK145603,
Zydelig (TN),
GS 1101,
Tube701,
cc-41,
MLS006010985,
Idelalisib (JAN/USAN/INN),
SCHEMBL356400,
C22H18FN7O,
GTPL6741,
QCR-36,
SCHEMBL16782604,
CAL-101/CAL101,
EX-A330,
GS-11CAL-101,
IFSDAJWBUCMOAH-HNNXBMFYSA-N,
BCPP000307,
AOB87313,
BCP02532,
EX-A1242,
KS-000007GA,
ABP000109,
BDBM50403068,
MFCD19443647,
s2226,
ZINC13986658,
AKOS022186334,
Idelalisib (CAL-101 GS-1101),
BCP9000471,
CS-0256,
DB09054,
LS41100,
PB25727,
RL05396,
Idelalisib (CAL-101, GS-1101),
CAL-101 (GS-1101),
NCGC00262603-01,
NCGC00262603-02,
AC-28394,
AJ-64558,
BC638838,
HY-13026,
SC-86075,
SMR004702787,
AX8224801,
ST2408278,
FT-0699107,
FT-0773473,
SW219823-1,
X7435,
D10560,
Q-4533,
J-517532,
BRD-K60866521-001-01-4,
CAL101;S2226;870281-82-6,
5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one,
5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-one,
(S)-2-(1-(1H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one,
(S)-5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one,
4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-,
40L,
Idelalisib [INN],
D0J5VR,
ACN-029571,
CID11625818,
PBCML-101 (Idelalisib, GS-1101),
A3005,
A10172,
C552946,
CAL-101, 99%, a selective p110delta inhibitor - 100MG 100mg,
5-fluoro-3-phenyl-2-[1-(7H-purin-6-ylamino)propyl]quinazolin-4-one,
870281-17-7,